| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| ARCA biopharma, Inc. | Director, Chairman of the Board | Common Stock | 50K | $125K | $2.50 | Jan 30, 2024 | Direct |
| ALPINE IMMUNE SCIENCES, INC. | Director | Common Stock | 0 | $0 | $6.33 | May 20, 2024 | By Robert E. Conway Rev Trust and Carolyn J. Conway Rev Trust |
| ARCA biopharma, Inc. | Director, Chairman of the Board | Stock Option (right to buy) | 6K | Jan 30, 2024 | Direct | ||
| ALPINE IMMUNE SCIENCES, INC. | Director | Stock Option (Right to buy) | 0 | May 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| ALPN | ALPINE IMMUNE SCIENCES, INC. | May 20, 2024 | 11 | $0 | 4 | May 20, 2024 | Director |
| ABIO | ARCA biopharma, Inc. | Jan 30, 2024 | 1 | $0 | 4 | Jan 31, 2024 | Director, Chairman of the Board |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 2, 2024 | 1 | $0 | 4 | Jan 4, 2024 | Director |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2023 | 1 | $0 | 4 | Jan 5, 2023 | Director |
| ABIO | ARCA biopharma, Inc. | Dec 15, 2022 | 1 | $0 | 4 | Dec 19, 2022 | Director, Chairman of the Board |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Jan 3, 2022 | 1 | $0 | 4 | Jan 4, 2022 | Director |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Sep 23, 2021 | 1 | $151K | 4/A | Sep 27, 2021 | Director |
| ALPN | ALPINE IMMUNE SCIENCES, INC. | Sep 21, 2021 | 1 | $98K | 4 | Sep 23, 2021 | Director |
| ABIO | ARCA biopharma, Inc. | May 13, 2021 | 1 | $31.9K | 4 | May 13, 2021 | Director, Chairman of the Board |